263271.fig.002a
(a)
263271.fig.002b
(b)
263271.fig.002c
(c)
Figure 2: Expression analysis of p16 and IFI16 in all 22 patients. (a) More patients were positive for p16, whereas no difference was observed in IFI16. (b and c) Expression of p16 (b) and IFI16 (c) according to clinical stages. Most of p16 positive patients were stage IVA.